(2R,3R,4S,5R,6R)-2-(2-(3-benzyl-2,3-dihydro-1H-benzo[d]imidazol-1-yl)ethoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

ID: ALA5287005

Max Phase: Preclinical

Molecular Formula: C22H28N2O6

Molecular Weight: 416.47

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OC[C@H]1O[C@@H](OCCN2CN(Cc3ccccc3)c3ccccc32)[C@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C22H28N2O6/c25-13-18-19(26)20(27)21(28)22(30-18)29-11-10-23-14-24(12-15-6-2-1-3-7-15)17-9-5-4-8-16(17)23/h1-9,18-22,25-28H,10-14H2/t18-,19+,20+,21-,22-/m1/s1

Standard InChI Key:  YRAXQDBZLUSJNH-CDJZJNNCSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    2.9802    0.5019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1925    0.2566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8699   -0.4598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0660   -0.3698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8919    0.4114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5890    0.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7698    1.6127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5543    1.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1561    1.3038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1948    0.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5022    0.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1993    0.8139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8964    0.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8964   -0.3936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1993   -0.7961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5937   -0.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5937   -1.6012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2909   -0.3936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9881   -0.7961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2909    0.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9881    0.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6851    0.4114    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5937    0.8140    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2724   -1.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0773   -1.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4800   -0.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2825   -0.4607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6851   -1.1579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2860   -1.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4815   -1.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  6  2  2  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
  1  9  2  0
 10  5  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  1
 14 13  1  0
 14 15  1  6
 16 14  1  0
 16 17  1  1
 18 16  1  0
 18 19  1  1
 20 18  1  0
 20 21  1  1
 21 22  1  0
 20 23  1  0
 13 23  1  0
  3 24  1  0
 24 25  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 29 28  1  0
 30 29  2  0
 25 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287005

    ---

Associated Targets(non-human)

BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.47Molecular Weight (Monoisotopic): 416.1947AlogP: 0.29#Rotatable Bonds: 7
Polar Surface Area: 105.86Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.21CX Basic pKa: CX LogP: 1.39CX LogD: 1.39
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.51Np Likeness Score: 0.65

References

1. Lopes JPB, Silva L, Lüdtke DS..  (2021)  An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases.,  12  (12.0): [PMID:35028560] [10.1039/D1MD00217A]

Source